Regulation of inflammation in cancer by dietary eicosanoids.

[1]  S. Hwang,et al.  Eicosanoid regulation of debris-stimulated metastasis , 2021, Proceedings of the National Academy of Sciences.

[2]  J. Vondráček,et al.  Deregulation of signaling pathways controlling cell survival and proliferation in cancer cells alters induction of cytochrome P450 family 1 enzymes. , 2021, Toxicology.

[3]  Chun-hua Song,et al.  Genetic variant of cyclooxygenase-2 in gastric cancer: More inflammation and susceptibility , 2021, World journal of gastroenterology.

[4]  V. Baladrón,et al.  The Role of Prostaglandins in Different Types of Cancer , 2021, Cells.

[5]  A. Edefonti,et al.  Role of Arachidonic Acid and Its Metabolites in the Biological and Clinical Manifestations of Idiopathic Nephrotic Syndrome , 2021, International journal of molecular sciences.

[6]  R. Dilger,et al.  Safety and Efficacy of Sodium and Potassium Arachidonic Acid Salts in the Young Pig , 2021, Nutrients.

[7]  Jiazhang Huang,et al.  Studying the Evaluation Model of the Nutritional Quality of Edible Vegetable Oil Based on Dietary Nutrient Reference Intake , 2021, ACS omega.

[8]  Bei Wang,et al.  Metabolism pathways of arachidonic acids: mechanisms and potential therapeutic targets , 2021, Signal Transduction and Targeted Therapy.

[9]  Fumiaki Beppu,et al.  Incorporation of Dietary Arachidonic and Docosatetraenoic Acid into Mouse Brain. , 2021, Journal of Agricultural and Food Chemistry.

[10]  S. Ahn,et al.  Targeted eicosanoids profiling reveals a prostaglandin reprogramming in breast Cancer by microRNA-155 , 2021, Journal of experimental & clinical cancer research : CR.

[11]  Yi Dai,et al.  Localization of prostaglandin E2 synthases and E-prostanoid receptors in the spinal cord in a rat model of neuropathic pain , 2020, Brain Research.

[12]  B. Datta,et al.  Small Molecule Soluble Epoxide Hydrolase Inhibitors in Multitarget and Combination Therapies for Inflammation and Cancer , 2020, Molecules.

[13]  Ang Chen,et al.  Investigation of the content differences of arachidonic acid metabolites in a mouse model of breast cancer by using LC-MS/MS. , 2020, Journal of pharmaceutical and biomedical analysis.

[14]  Jun-Yan Liu,et al.  Pleiotropic Functions of Cytochrome P450 Monooxygenase-Derived Eicosanoids in Cancer , 2020, Frontiers in Pharmacology.

[15]  L. Coolen,et al.  20-HETE Enzymes and Receptors in the Neurovascular Unit: Implications in Cerebrovascular Disease , 2020, Frontiers in Neurology.

[16]  Sui Huang,et al.  Resolution of eicosanoid/cytokine storm prevents carcinogen and inflammation-initiated hepatocellular cancer progression , 2020, Proceedings of the National Academy of Sciences.

[17]  J. Haeggström,et al.  Integral membrane enzymes in eicosanoid metabolism: Structures, mechanisms and inhibitor design. , 2020, Journal of molecular biology.

[18]  Sui Huang,et al.  Inflammation resolution: a dual-pronged approach to averting cytokine storms in COVID-19? , 2020, Cancer and Metastasis Reviews.

[19]  U. Jeschke,et al.  COX-2-PGE2-EPs in gynecological cancers , 2020, Archives of Gynecology and Obstetrics.

[20]  Takehiro Hirano,et al.  Immunological Mechanisms in Inflammation-Associated Colon Carcinogenesis , 2020, International journal of molecular sciences.

[21]  S. Hwang,et al.  A COX-2/sEH dual inhibitor PTUPB alleviates lipopolysaccharide-induced acute lung injury in mice by inhibiting NLRP3 inflammasome activation , 2020, Theranostics.

[22]  N. Salem,et al.  Arachidonic Acid in Human Milk , 2020, Nutrients.

[23]  M. Lupu,et al.  COX-2 as a potential biomarker and therapeutic target in melanoma , 2020, Cancer biology & medicine.

[24]  Yu-Chih Yang,et al.  Deregulating the CYP2C19/Epoxy-Eicosatrienoic Acid-Associated FABP4/FABP5 Signaling Network as a Therapeutic Approach for Metastatic Triple-Negative Breast Cancer , 2020, Cancers.

[25]  Daowen Wang,et al.  sEH Inhibitor Tppu Ameliorates Cecal Ligation and Puncture-Induced Sepsis by Regulating Macrophage Functions , 2020, Shock.

[26]  Daowen Wang,et al.  PPARα ligand, AVE8134, and cyclooxygenase inhibitor therapy synergistically suppress lung cancer growth and metastasis , 2019, BMC Cancer.

[27]  M. Thorsteinsdóttir,et al.  Valuable Fatty Acids in Bryophytes—Production, Biosynthesis, Analysis and Applications , 2019, Plants.

[28]  Weiya Ma,et al.  Targeting the COX1/2-Driven thromboxane A2 pathway suppresses Barrett's esophagus and esophageal adenocarcinoma development , 2019, EBioMedicine.

[29]  J. Mei,et al.  Cyclooxygenase-2 in Endometriosis , 2019, International journal of biological sciences.

[30]  B. Hammock,et al.  Epoxyeicosatrienoic acid (EET)-stimulated angiogenesis is mediated by epoxy hydroxyeicosatrienoic acids (EHETs) formed from COX-2[S] , 2019, Journal of Lipid Research.

[31]  Erik Froyen,et al.  Alpha-Linolenic and Linoleic Fatty Acids in the Vegan Diet: Do They Require Dietary Reference Intake/Adequate Intake Special Consideration? , 2019, Nutrients.

[32]  J. Um,et al.  Zileuton, a 5-Lipoxygenase Inhibitor, Exerts Anti-Angiogenic Effect by Inducing Apoptosis of HUVEC via BK Channel Activation , 2019, Cells.

[33]  S. Hwang,et al.  Effect Of Dual sEH/COX-2 Inhibition on Allergen-Induced Airway Inflammation , 2019, Front. Pharmacol..

[34]  L. AL-Eitan,et al.  Association of CYP gene polymorphisms with breast cancer risk and prognostic factors in the Jordanian population , 2019, BMC Medical Genetics.

[35]  Su-Jun Lee,et al.  Molecular Functionality of Cytochrome P450 4 (CYP4) Genetic Polymorphisms and Their Clinical Implications , 2019, International journal of molecular sciences.

[36]  Yanzhuo Liu,et al.  Inhibition of COX-2, mPGES-1 and CYP4A by isoliquiritigenin blocks the angiogenic Akt signaling in glioma through ceRNA effect of miR-194-5p and lncRNA NEAT1 , 2019, Journal of experimental & clinical cancer research : CR.

[37]  D. Magee,et al.  Nonsteroidal anti-inflammatory drugs and pain in cancer patients: a systematic review and reappraisal of the evidence. , 2019, British journal of anaesthesia.

[38]  Z. Gai,et al.  Arachidonic Acid Metabolism and Kidney Inflammation , 2019, International journal of molecular sciences.

[39]  Deepak Baby,et al.  Inflammation and Cancer , 2019, Annals of African medicine.

[40]  F. Greten,et al.  Inflammation and Cancer: Triggers, Mechanisms, and Consequences. , 2019, Immunity.

[41]  Varnavas D. Mouchlis,et al.  Phospholipase A2 catalysis and lipid mediator lipidomics. , 2019, Biochimica et biophysica acta. Molecular and cell biology of lipids.

[42]  N. Müller.  COX-2 Inhibitors, Aspirin, and Other Potential Anti-Inflammatory Treatments for Psychiatric Disorders , 2019, Front. Psychiatry.

[43]  H. Kawashima.  Intake of arachidonic acid-containing lipids in adult humans: dietary surveys and clinical trials , 2019, Lipids in Health and Disease.

[44]  Q. Jarrar,et al.  Effects of nonsteroidal anti-inflammatory drugs on the expression of arachidonic acid-metabolizing Cyp450 genes in mouse hearts, kidneys and livers. , 2019, Prostaglandins & other lipid mediators.

[45]  M. Burdick,et al.  Leukotriene A4 Hydrolase Activation and Leukotriene B4 Production by Eosinophils in Severe Asthma , 2019, American journal of respiratory cell and molecular biology.

[46]  W. Miltyk,et al.  Celecoxib in Cancer Therapy and Prevention - Review. , 2019, Current drug targets.

[47]  Sui Huang,et al.  Suppression of chemotherapy-induced cytokine/lipid mediator surge and ovarian cancer by a dual COX-2/sEH inhibitor , 2019, Proceedings of the National Academy of Sciences.

[48]  J. Mitchell,et al.  Eicosanoids, prostacyclin and cyclooxygenase in the cardiovascular system , 2018, British journal of pharmacology.

[49]  P. Hartge,et al.  Prediagnostic Serum Levels of Fatty Acid Metabolites and Risk of Ovarian Cancer in the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial , 2018, Cancer Epidemiology, Biomarkers & Prevention.

[50]  Zhexing Shou,et al.  Correlations between CYP3A4 polymorphism and susceptibility to breast cancer in Chinese Han population , 2018, International Journal of Clinical Oncology.

[51]  J. Katzenellenbogen,et al.  Discovery of long-chain salicylketoxime derivatives as monoacylglycerol lipase (MAGL) inhibitors. , 2018, European journal of medicinal chemistry.

[52]  G. Booz,et al.  Conflicting roles of 20-HETE in hypertension and renal end organ damage. , 2018, European journal of pharmacology.

[53]  H. O’Hagan,et al.  The Role of Inflammation and Inflammatory Mediators in the Development, Progression, Metastasis, and Chemoresistance of Epithelial Ovarian Cancer , 2018, Cancers.

[54]  W. Xiao,et al.  A RIPK3-PGE2 Circuit Mediates Myeloid-Derived Suppressor Cell-Potentiated Colorectal Carcinogenesis. , 2018, Cancer research.

[55]  D. Panigrahy,et al.  Drawing a link between the thromboxane A2 pathway and the role of platelets and tumor cells in ovarian cancer. , 2018, Prostaglandins & other lipid mediators.

[56]  Jie Zhang,et al.  PGD2/PTGDR2 Signaling Restricts the Self‐Renewal and Tumorigenesis of Gastric Cancer , 2018, Stem cells.

[57]  Kuo-Wei Chang,et al.  Eicosanoids and HB-EGF/EGFR in cancer , 2018, Cancer and Metastasis Reviews.

[58]  A. Sood,et al.  Stress, inflammation, and eicosanoids: an emerging perspective , 2018, Cancer and Metastasis Reviews.

[59]  B. Sitek,et al.  Alterations in NO- and PGI2- dependent function in aorta in the orthotopic murine model of metastatic 4T1 breast cancer: relationship with pulmonary endothelial dysfunction and systemic inflammation , 2018, BMC Cancer.

[60]  Jian Zhang,et al.  Lipoxin A4 and its analog suppress hepatocarcinoma cell epithelial-mesenchymal transition, migration and metastasis via regulating integrin-linked kinase axis. , 2018, Prostaglandins & other lipid mediators.

[61]  G. Storm,et al.  Reprogramming tumor stroma using an endogenous lipid lipoxin A4 to treat pancreatic cancer. , 2018, Cancer letters.

[62]  J. Boyle,et al.  Celecoxib exerts protective effects in the vascular endothelium via COX-2-independent activation of AMPK-CREB-Nrf2 signalling , 2018, Scientific Reports.

[63]  S. Shanab,et al.  A review on algae and plants as potential source of arachidonic acid , 2018, Journal of advanced research.

[64]  Y. Huang,et al.  14, 15-EET induces breast cancer cell EMT and cisplatin resistance by up-regulating integrin αvβ3 and activating FAK/PI3K/AKT signaling , 2018, Journal of experimental & clinical cancer research : CR.

[65]  A. Colquhoun,et al.  Opposing roles of PGD2 in GBM. , 2017, Prostaglandins & other lipid mediators.

[66]  Z. Wang,et al.  Lipoxin A4 reverses mesenchymal phenotypes to attenuate invasion and metastasis via the inhibition of autocrine TGF-β1 signaling in pancreatic cancer , 2017, Journal of experimental & clinical cancer research : CR.

[67]  B. Kinsella,et al.  Regulated expression of the TPβ isoform of the human T prostanoid receptor by the tumour suppressors FOXP1 and NKX3.1: Implications for the role of thromboxane in prostate cancer. , 2017, Biochimica et biophysica acta. Molecular basis of disease.

[68]  A. Arbab,et al.  Arachidonic Acid Metabolite as a Novel Therapeutic Target in Breast Cancer Metastasis , 2017, International journal of molecular sciences.

[69]  V. Jala,et al.  The yin and yang of leukotriene B4 mediated inflammation in cancer. , 2017, Seminars in immunology.

[70]  A. Arbab,et al.  Vascular mimicry in glioblastoma following anti-angiogenic and anti-20-HETE therapies. , 2017, Histology and histopathology.

[71]  R. Knight,et al.  Leukotriene B4-receptor-1 mediated host response shapes gut microbiota and controls colon tumor progression , 2017, Oncoimmunology.

[72]  L. Dwyer-Nield,et al.  The Second-Generation PGI2 Analogue Treprostinil Fails to Chemoprevent Tumors in a Murine Lung Adenocarcinoma Model , 2017, Cancer Prevention Research.

[73]  Ji Won Kim,et al.  Role of the CYP3A4-mediated 11,12-epoxyeicosatrienoic acid pathway in the development of tamoxifen-resistant breast cancer , 2017, Oncotarget.

[74]  J. Baron,et al.  Plasma lipoxin A4 and resolvin D1 are not associated with reduced adenoma risk in a randomized trial of aspirin to prevent colon adenomas , 2017, Molecular carcinogenesis.

[75]  A. Arbab,et al.  HET0016 decreases lung metastasis from breast cancer in immune-competent mouse model , 2017, PloS one.

[76]  E. Antman.  Evaluating the Cardiovascular Safety of Nonsteroidal Anti-Inflammatory Drugs. , 2017, Circulation.

[77]  A. Bode,et al.  Inhibiting breast cancer by targeting the thromboxane A2 pathway , 2017, npj Precision Oncology.

[78]  D. Curiel,et al.  COX2/mPGES1/PGE2 pathway regulates PD-L1 expression in tumor-associated macrophages and myeloid-derived suppressor cells , 2017, Proceedings of the National Academy of Sciences.

[79]  I. Roitt,et al.  Lipoxin A4 selectively programs the profile of M2 tumor‐associated macrophages which favour control of tumor progression , 2017, International journal of cancer.

[80]  H. Qiu,et al.  Critical Role of LTB4/BLT1 in IL-23–Induced Synovial Inflammation and Osteoclastogenesis via NF-κB , 2017, The Journal of Immunology.

[81]  Huwei Liu,et al.  Distinct differences in serum eicosanoids in healthy, enteritis and colorectal cancer individuals , 2017, Metabolomics.

[82]  D. El-Lebedy,et al.  Genetic polymorphisms of human cytochrome P450 CYP1A1 in an Egyptian population and tobacco-induced lung cancer , 2017, Genes and Environment.

[83]  P. Nandi,et al.  PGE2 promotes breast cancer-associated lymphangiogenesis by activation of EP4 receptor on lymphatic endothelial cells , 2017, BMC Cancer.

[84]  J. O’Sullivan,et al.  Evaluation of Cysteinyl Leukotriene Signaling as a Therapeutic Target for Colorectal Cancer , 2016, Front. Cell Dev. Biol..

[85]  V. Jala,et al.  Chemoattractant Receptors BLT1 and CXCR3 Regulate Antitumor Immunity by Facilitating CD8+ T Cell Migration into Tumors , 2016, The Journal of Immunology.

[86]  S. Forsyth,et al.  Global Estimates of Dietary Intake of Docosahexaenoic Acid and Arachidonic Acid in Developing and Developed Countries , 2016, Annals of Nutrition and Metabolism.

[87]  Mauro M. Teixeira,et al.  Resolution of Inflammation: What Controls Its Onset? , 2016, Front. Immunol..

[88]  G. Chen,et al.  Cytochrome P450 1A2 Metabolizes 17β-Estradiol to Suppress Hepatocellular Carcinoma , 2016, PloS one.

[89]  M. Huang,et al.  Cysteinyl Leukotriene Receptor Antagonists Decrease Cancer Risk in Asthma Patients , 2016, Scientific Reports.

[90]  N. Salem,et al.  The Essentiality of Arachidonic Acid in Infant Development , 2016, Nutrients.

[91]  T. Taniguchi,et al.  PGE2 induced in and released by dying cells functions as an inhibitory DAMP , 2016, Proceedings of the National Academy of Sciences.

[92]  Osamu Hirose,et al.  Inflammation in gastric cancer: Interplay of the COX‐2/prostaglandin E2 and Toll‐like receptor/MyD88 pathways , 2016, Cancer science.

[93]  T. Mikkelsen,et al.  Combination of vatalanib and a 20-HETE synthesis inhibitor results in decreased tumor growth in an animal model of human glioma , 2016, OncoTargets and therapy.

[94]  Robert C Murphy,et al.  Deletion of 5-Lipoxygenase in the Tumor Microenvironment Promotes Lung Cancer Progression and Metastasis through Regulating T Cell Recruitment , 2016, The Journal of Immunology.

[95]  Je Min Lee,et al.  Fatty Acid Desaturases, Polyunsaturated Fatty Acid Regulation, and Biotechnological Advances , 2016, Nutrients.

[96]  Q. Ma,et al.  Lipoxin A4 Attenuates Cell Invasion by Inhibiting ROS/ERK/MMP Pathway in Pancreatic Cancer , 2015, Oxidative medicine and cellular longevity.

[97]  R. DuBois,et al.  Prostaglandin E2 Promotes Colorectal Cancer Stem Cell Expansion and Metastasis in Mice. , 2015, Gastroenterology.

[98]  Sreeparna Banerjee,et al.  Eicosanoid pathway in colorectal cancer: Recent updates. , 2015, World journal of gastroenterology.

[99]  M. Yashiro,et al.  Prostaglandin d synthase is a potential novel therapeutic agent for the treatment of gastric carcinomas expressing PPARγ , 2015, International journal of cancer.

[100]  Z. Wang,et al.  Lipid mediator lipoxin A4 inhibits tumor growth by targeting IL-10-producing regulatory B (Breg) cells. , 2015, Cancer letters.

[101]  F. Balkwill,et al.  Inflammation and cancer: advances and new agents , 2015, Nature Reviews Clinical Oncology.

[102]  H. Kuhn,et al.  Mammalian lipoxygenases and their biological relevance. , 2015, Biochimica et biophysica acta.

[103]  H. Sasano,et al.  Prostaglandin E2 inhibits p53 in human breast adipose stromal cells: a novel mechanism for the regulation of aromatase in obesity and breast cancer. , 2015, Cancer research.

[104]  J. Kawabe,et al.  Prostaglandin I2 analog suppresses lung metastasis by recruiting pericytes in tumor angiogenesis. , 2015, International journal of oncology.

[105]  J. Olefsky,et al.  LTB4 causes macrophage–mediated inflammation and directly induces insulin resistance in obesity , 2015, Nature medicine.

[106]  Philip Levy Ho,et al.  Blocking PGE2-induced tumour repopulation abrogates bladder cancer chemoresistance , 2014, Nature.

[107]  R. Murphy,et al.  The role of PGE2 in intestinal inflammation and tumorigenesis. , 2015, Prostaglandins & other lipid mediators.

[108]  R. Sears,et al.  Inhibition of 5-Lipoxygenase Selectively Triggers Disruption of c-Myc Signaling in Prostate Cancer Cells* , 2014, The Journal of Biological Chemistry.

[109]  D. Pennington,et al.  Cytokines and chemokines: At the crossroads of cell signalling and inflammatory disease. , 2014, Biochimica et biophysica acta.

[110]  R. DuBois,et al.  PPARδ and PGE2 signaling pathways communicate and connect inflammation to colorectal cancer. , 2014, Inflammation and cell signaling.

[111]  T. Seki,et al.  Combined therapy with COX-2 inhibitor and 20-HETE inhibitor reduces colon tumor growth and the adverse effects of ischemic stroke associated with COX-2 inhibition. , 2014, American journal of physiology. Regulatory, integrative and comparative physiology.

[112]  A. Brenner,et al.  NSAID use reduces breast cancer recurrence in overweight and obese women: role of prostaglandin-aromatase interactions. , 2014, Cancer research.

[113]  Y. Urade,et al.  Mast cell-derived prostaglandin D2 inhibits colitis and colitis-associated colon cancer in mice. , 2014, Cancer research.

[114]  Mireille Alhouayek,et al.  COX-2-derived endocannabinoid metabolites as novel inflammatory mediators. , 2014, Trends in pharmacological sciences.

[115]  S. Misra,et al.  COX-2 signaling and cancer: new players in old arena. , 2014, Current drug targets.

[116]  Yuan Zhang,et al.  Cysteinyl leukotrienes and their receptors: bridging inflammation and colorectal cancer. , 2014, World journal of gastroenterology.

[117]  G. Núñez,et al.  Gut dysbiosis promotes M2 macrophage polarization and allergic airway inflammation via fungi-induced PGE₂. , 2014, Cell host & microbe.

[118]  B. Hammock,et al.  Stabilized epoxygenated fatty acids regulate inflammation, pain, angiogenesis and cancer. , 2014, Progress in lipid research.

[119]  M. Underwood,et al.  Thromboxane A2 receptor α promotes tumor growth through an autoregulatory feedback pathway. , 2013, Journal of molecular cell biology.

[120]  R. Murphy,et al.  Eicosanoid Profiling in an Orthotopic Model of Lung Cancer Progression by Mass Spectrometry Demonstrates Selective Production of Leukotrienes by Inflammatory Cells of the Microenvironment , 2013, PloS one.

[121]  R. Reski,et al.  High contents of very long-chain polyunsaturated fatty acids in different moss species , 2013, Plant Cell Reports.

[122]  Jae-Gook Shin,et al.  Identification of cytochrome P450s involved in the metabolism of arachidonic acid in human platelets. , 2013, Prostaglandins, leukotrienes, and essential fatty acids.

[123]  K. Bishayee,et al.  5-lipoxygenase antagonist therapy: a new approach towards targeted cancer chemotherapy. , 2013, Acta biochimica et biophysica Sinica.

[124]  Daowen Wang,et al.  CYP epoxygenase derived EETs: from cardiovascular protection to human cancer therapy. , 2013, Current topics in medicinal chemistry.

[125]  Dale P Sandler,et al.  Association between Urinary Prostaglandin E2 Metabolite and Breast Cancer Risk: A Prospective, Case–Cohort Study of Postmenopausal Women , 2013, Cancer Prevention Research.

[126]  A. Sorokin,et al.  Targeting 20-HETE producing enzymes in cancer – rationale, pharmacology, and clinical potential , 2013, OncoTargets and therapy.

[127]  M. Majima,et al.  Tumor apoptosis in prostate cancer by PGD(2) and its metabolite 15d-PGJ(2) in murine model. , 2013, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[128]  M. Oshima,et al.  The role of PGE2-associated inflammatory responses in gastric cancer development , 2013, Seminars in Immunopathology.

[129]  A. Sim,et al.  Eosinophils in human oral squamous carcinoma; role of prostaglandin D2 , 2013, Journal of Inflammation.

[130]  C. Serhan,et al.  Pro-Resolving Lipid Mediators (SPMs) and Their Actions in Regulating miRNA in Novel Resolution Circuits in Inflammation , 2012, Front. Immun..

[131]  R. Peebles,et al.  PGI2 as a Regulator of Inflammatory Diseases , 2012, Mediators of inflammation.

[132]  S. Akira,et al.  Microsomal prostaglandin E synthase-1 is involved in multiple steps of colon carcinogenesis , 2012, Oncogene.

[133]  C. Hudis,et al.  Increased levels of COX-2 and prostaglandin E2 contribute to elevated aromatase expression in inflamed breast tissue of obese women. , 2012, Cancer discovery.

[134]  Jae-Hong Kim,et al.  Leukotriene B4 Receptor-2 Promotes Invasiveness and Metastasis of Ovarian Cancer Cells through Signal Transducer and Activator of Transcription 3 (STAT3)-dependent Up-regulation of Matrix Metalloproteinase 2* , 2012, The Journal of Biological Chemistry.

[135]  Donald E Ingber,et al.  Epoxyeicosanoids stimulate multiorgan metastasis and tumor dormancy escape in mice. , 2012, The Journal of clinical investigation.

[136]  R. Roman,et al.  20‐HETE producing enzymes are upregulated in human cancers , 2011, Cancer genomics & proteomics.

[137]  J. Haeggström,et al.  The leukotrienes: immune-modulating lipid mediators of disease. , 2012, Advances in immunology.

[138]  Q. Mao-Ying,et al.  Lipoxins and aspirin-triggered lipoxin alleviate bone cancer pain in association with suppressing expression of spinal proinflammatory cytokines , 2012, Journal of Neuroinflammation.

[139]  C. Brodie,et al.  Inhibition of 5-lipoxygenase triggers apoptosis in prostate cancer cells via down-regulation of protein kinase C-epsilon. , 2011, Biochimica et biophysica acta.

[140]  Y. Urade,et al.  Prostagladin D2 is a mast cell-derived antiangiogenic factor in lung carcinoma , 2011, Proceedings of the National Academy of Sciences.

[141]  M. Hamberg,et al.  Stereoselective oxidation of regioisomeric octadecenoic acids by fatty acid dioxygenases , 2011, Journal of Lipid Research.

[142]  E. P. Chen,et al.  COX-2 and PGE2-dependent immunomodulation in breast cancer. , 2011, Prostaglandins & other lipid mediators.

[143]  C. Rao,et al.  Role of lipoxins, resolvins, and other bioactive lipids in colon and pancreatic cancer , 2011, Cancer and Metastasis Reviews.

[144]  A. Pozzi,et al.  EET signaling in cancer , 2011, Cancer and Metastasis Reviews.

[145]  Claus Schneider,et al.  Cyclooxygenases and lipoxygenases in cancer , 2011, Cancer and Metastasis Reviews.

[146]  V. Steele,et al.  Chemoprevention of Colon and Small Intestinal Tumorigenesis in APCMin/+ Mice by Licofelone, a Novel Dual 5-LOX/COX Inhibitor: Potential Implications for Human Colon Cancer Prevention , 2011, Cancer Prevention Research.

[147]  J. Chang,et al.  Monoacylglycerol lipase exerts dual control over endocannabinoid and fatty acid pathways to support prostate cancer. , 2011, Chemistry & biology.

[148]  Xin A. Zhang,et al.  The roles of CYP450 epoxygenases and metabolites, epoxyeicosatrienoic acids, in cardiovascular and malignant diseases. , 2011, Advanced drug delivery reviews.

[149]  Takuji Tanaka,et al.  Selective PGE2 Suppression Inhibits Colon Carcinogenesis and Modifies Local Mucosal Immunity , 2011, Cancer Prevention Research.

[150]  Mingxin Zhang,et al.  Prostacyclin administration as a beneficial supplement to the conventional cancer chemotherapy. , 2011, Medical hypotheses.

[151]  S. Hirota,et al.  Age-related changes of dietary intake and blood eicosapentaenoic acid, docosahexaenoic acid, and arachidonic acid levels in Japanese men and women. , 2011, Prostaglandins, leukotrienes, and essential fatty acids.

[152]  Garret A. FitzGerald,et al.  Prostaglandins and Inflammation , 2011, Arteriosclerosis, thrombosis, and vascular biology.

[153]  D. Bentrem,et al.  Mast cell 5-lipoxygenase activity promotes intestinal polyposis in APCDelta468 mice. , 2011, Cancer research.

[154]  Sui Huang,et al.  Cytochrome P450-derived eicosanoids: the neglected pathway in cancer , 2010, Cancer and Metastasis Reviews.

[155]  R. Roman,et al.  20-Hydroxyeicosatetraeonic Acid: A New Target for the Treatment of Hypertension , 2010, Journal of cardiovascular pharmacology.

[156]  Manoj Kumar,et al.  Biochemical responses of red alga Gracilaria corticata (Gracilariales, Rhodophyta) to salinity induced oxidative stress , 2010 .

[157]  R. DuBois,et al.  Eicosanoids and cancer , 2010, Nature Reviews Cancer.

[158]  A. Rettie,et al.  Expression and Characterization of CYP4V2 as a Fatty Acid ω-Hydroxylase , 2009, Drug Metabolism and Disposition.

[159]  R. Totah,et al.  Epoxyeicosatrienoic acids: formation, metabolism and potential role in tissue physiology and pathophysiology , 2009, Expert opinion on drug metabolism & toxicology.

[160]  Yinping Huang,et al.  Effects of Lipoxin A4 on CoCl2-Induced Angiogenesis and Its Possible Mechanisms in Human Umbilical Vein Endothelial Cells , 2009, Pharmacology.

[161]  S. Narumiya,et al.  Role of prostaglandin D2 receptor DP as a suppressor of tumor hyperpermeability and angiogenesis in vivo , 2008, Proceedings of the National Academy of Sciences.

[162]  N. Lehman,et al.  Expression of CYP4A1 in U251 Human Glioma Cell Induces Hyperproliferative Phenotype in Vitro and Rapidly Growing Tumors in Vivo , 2008, Journal of Pharmacology and Experimental Therapeutics.

[163]  S. Narumiya,et al.  Prostacyclin Prevents Murine Lung Cancer Independent of the Membrane Receptor by Activation of Peroxisomal Proliferator–Activated Receptor γ , 2008, Cancer Prevention Research.

[164]  D. Bentrem,et al.  Overexpression of 5-Lipoxygenase in Colon Polyps and Cancer and the Effect of 5-LOX Inhibitors In vitro and in a Murine Model , 2008, Clinical Cancer Research.

[165]  I. Edwards,et al.  Omega-3 Fatty Acids and PPARγ in Cancer , 2008, PPAR research.

[166]  K. Al-Kuraya,et al.  Polymorphisms of selected Xenobiotic Genes contribute to the development of Papillary Thyroid Cancer susceptibility in Middle Eastern population , 2008, BMC Medical Genetics.

[167]  P. Clark,et al.  Genetic deletion of mPGES-1 suppresses intestinal tumorigenesis. , 2008, Cancer research.

[168]  D. Hommes,et al.  High frequency of early colorectal cancer in inflammatory bowel disease , 2008, Gut.

[169]  A. Tenesa,et al.  Dietary fatty acids and colorectal cancer: a case-control study. , 2007, American journal of epidemiology.

[170]  L. Arterburn,et al.  Docosahexaenoic and arachidonic acid concentrations in human breast milk worldwide. , 2007, The American journal of clinical nutrition.

[171]  Trevor T. Hansel,et al.  Antagonism of the prostaglandin D2 receptors DP1 and CRTH2 as an approach to treat allergic diseases , 2007, Nature Reviews Drug Discovery.

[172]  H. Hercule,et al.  Mouse Cyp4a isoforms: enzymatic properties, gender- and strain-specific expression, and role in renal 20-hydroxyeicosatetraenoic acid formation. , 2007, The Biochemical journal.

[173]  F. Clavel-Chapelon,et al.  Polymorphisms in Metabolic Genes Related to Tobacco Smoke and the Risk of Gastric Cancer in the European Prospective Investigation into Cancer and Nutrition , 2006, Cancer Epidemiology Biomarkers & Prevention.

[174]  Chung S. Yang,et al.  Five-lipoxygenase pathway of arachidonic acid metabolism in carcino-genesis and cancer chemoprevention. , 2006, Current cancer drug targets.

[175]  A. Sjölander,et al.  The Inflammatory Mediator Leukotriene D4 Induces β-Catenin Signaling and Its Association with Antiapoptotic Bcl-2 in Intestinal Epithelial Cells* , 2006, Journal of Biological Chemistry.

[176]  D. Praticò,et al.  Thromboxane, prostacyclin and isoprostanes: therapeutic targets in atherogenesis. , 2005, Trends in pharmacological sciences.

[177]  C. Serhan,et al.  Anti-inflammatory circuitry: lipoxin, aspirin-triggered lipoxins and their receptor ALX. , 2005, Prostaglandins, leukotrienes, and essential fatty acids.

[178]  M. Rydzanicz,et al.  CYP1A1, CYP2D6, CYP2E1, NAT2, GSTM1 and GSTT1 polymorphisms or their combinations are associated with the increased risk of the laryngeal squamous cell carcinoma. , 2005, Mutation research.

[179]  D. Zeldin,et al.  Cytochrome P450 2J2 promotes the neoplastic phenotype of carcinoma cells and is up-regulated in human tumors. , 2005, Cancer research.

[180]  R. DuBois,et al.  The role of prostaglandins and other eicosanoids in the gastrointestinal tract. , 2005, Gastroenterology.

[181]  J. McHowat,et al.  Phospholipase A2 inhibitors as potential anti-inflammatory agents. , 2005, Current pharmaceutical design.

[182]  Robert Riddell,et al.  Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial. , 2005, The New England journal of medicine.

[183]  Eunjung Kim,et al.  An antitumorigenic role for murine 8S-lipoxygenase in skin carcinogenesis , 2005, Oncogene.

[184]  T. Shimoyama,et al.  Effect of leukotriene C4D4 antagonist on colonic damage induced by intracolonic administration of trinitrobenzene sulfonic acid in rats , 1995, Journal of Gastroenterology.

[185]  E. Platz,et al.  Epidemiology of inflammation and prostate cancer. , 2004, The Journal of urology.

[186]  S. Paruchuri,et al.  Leukotriene D4 Mediates Survival and Proliferation via Separate but Parallel Pathways in the Human Intestinal Epithelial Cell Line Int 407* , 2003, Journal of Biological Chemistry.

[187]  D. Busija,et al.  Putative Cyclooxygenase-3 Expression in Rat Brain Cells , 2003, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[188]  G. Landberg,et al.  Expression of the leukotriene D4 receptor CysLT1, COX-2, and other cell survival factors in colorectal adenocarcinomas. , 2003, Gastroenterology.

[189]  L. Coussens,et al.  Inflammation and cancer , 2002, Nature.

[190]  Xìao-chun Xu.  COX-2 inhibitors in cancer treatment and prevention, a recent development. , 2002, Anti-cancer drugs.

[191]  C. Bigogno,et al.  Biosynthesis of arachidonic acid in the oleaginous microalga Parietochloris incisa (Chlorophyceae): Radiolabeling studies , 2002, Lipids.

[192]  A. Sher,et al.  Lipoxin-mediated inhibition of IL-12 production by DCs: a mechanism for regulation of microbial immunity , 2002, Nature Immunology.

[193]  F. Fitzpatrick,et al.  Regulated formation of eicosanoids. , 2001, The Journal of clinical investigation.

[194]  A. Brash.  Arachidonic acid as a bioactive molecule. , 2001, The Journal of clinical investigation.

[195]  C. Denkert,et al.  Expression of cyclooxygenase 2 in human malignant melanoma. , 2001, Cancer research.

[196]  B D Hammock,et al.  Soluble Epoxide Hydrolase Regulates Hydrolysis of Vasoactive Epoxyeicosatrienoic Acids , 2000, Circulation research.

[197]  A. Sjölander,et al.  Leukotrienes induce cell-survival signaling in intestinal epithelial cells. , 2000, Gastroenterology.

[198]  J. Gelin,et al.  Effect of cyclooxygenase and nitric oxide synthase inhibitors on tumor growth in mouse tumor models with and without cancer cachexia related to prostanoids. , 2000, Cancer research.

[199]  J. Whelan,et al.  Assessment of the arachidonic acid content in foods commonly consumed in the American diet , 1998, Lipids.

[200]  C. Myers,et al.  Inhibition of arachidonate 5-lipoxygenase triggers massive apoptosis in human prostate cancer cells. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[201]  Duo Li,et al.  Contribution of meat fat to dietary arachidonic acid , 1998, Lipids.

[202]  A. Sinclair,et al.  The arachidonic acid content of the Australian diet is lower than previously estimated. , 1995, The Journal of nutrition.

[203]  J. Whelan,et al.  Antithetic relationship of dietary arachidonic acid and eicosapentaenoic acid on eicosanoid production in vivo. , 1994, Journal of lipid research.

[204]  S. Yamamoto,et al.  Lipoxin synthase activity of human platelet 12-lipoxygenase. , 1993, The Biochemical journal.

[205]  B. Samuelsson,et al.  Cyclic AMP inhibits synthesis of prostaglandin endoperoxide (PGG2) in human platelets. , 1976, Biochemical and Biophysical Research Communications - BBRC.

[206]  Yoko Yamamoto,et al.  FATTY ACID COMPOSITION OF LICHENS AND THEIR PHYCO- AND MYCOBIONTS , 1974 .